Literature DB >> 10937460

Effects of antipsychotics on the unborn child: what is known and how should this influence prescribing?

H B Pinkofsky1.   

Abstract

The onset of psychosis during pregnancy presents difficult management decisions. A complete and thorough physical and obstetric examination is always warranted to look for possible physiological precipitants. The treatment of pregnant patients with psychotic symptomatology requires close contacts between family members, non-physician professionals involved in the patient's care (e.g. social workers, case managers and home healthcare nurses), and the physicians overseeing the patient's management (e.g. internists, obstetricians and psychiatrists). In mild and less disabling cases it may be possible to avoid medication intervention but this approach risks adverse behaviour consequences resulting from a possible worsening of the patient's symptomatology. Avoiding medication requires an environment in which the patient has strong social supports. Risks are present whether medication is initiated or not, and treatment decisions require a careful assessment of the risks and benefits involved. Initiating medication raises the possibility of obstetric, teratogenic, neurobehavioural and neonatal toxic effects. Research on the risks imposed by antipsychotic drug use during pregnancy is incomplete and raises questions regarding appropriate management. The first trimester represents a period of increased susceptibility to medication-induced teratogenesis. The use of low potency phenothiazines during the first trimester may increase the risk of congenital abnormalities by an additional 4 cases per 1000 (odds ratio = 1.21, p = 0.04) The pharmacological profiles of antipsychotic medications also present adverse effects which need to be considered during pregnancy (hypotension, sedation, etc.). Less is known about the risk of adverse consequences resulting from the use of newer atypical antipsychotic medications. Electroconvulsive therapy is another treatment modality and its use may circumvent the need to introduce antipsychotic medication during pregnancy. It must be stressed that. given current knowledge, no treatment regimen can be considered completely safe. Ultimately many factors must be evaluated when treating psychosis during pregnancy, however, no decision is risk-free.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10937460     DOI: 10.2165/00148581-200002020-00001

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  65 in total

Review 1.  Psychotropic medication use during pregnancy.

Authors:  B H Guze; P A Guze
Journal:  West J Med       Date:  1989-09

2.  The offspring of schizophrenics. Fetal and neonatal deaths.

Authors:  R O Rieder; D Rosenthal; P Wender; H Blumenthal
Journal:  Arch Gen Psychiatry       Date:  1975-02

3.  Fluphenazine decanoate during pregnancy.

Authors:  M F Cleary
Journal:  Am J Psychiatry       Date:  1977-07       Impact factor: 18.112

4.  Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk.

Authors:  C Barnas; A Bergant; M Hummer; A Saria; W W Fleischhacker
Journal:  Am J Psychiatry       Date:  1994-06       Impact factor: 18.112

5.  Neuroleptic withdrawal in schizophrenic patients.

Authors:  R J Baldessarini; A C Viguera
Journal:  Arch Gen Psychiatry       Date:  1995-03

Review 6.  Psychotropic drugs in pregnancy and lactation.

Authors:  H L Goldberg
Journal:  Int J Psychiatry Med       Date:  1994       Impact factor: 1.210

7.  Intrauterine effect of phenothiazines.

Authors:  M O'Connor; G H Johnson; D I James
Journal:  Med J Aust       Date:  1981-04-18       Impact factor: 7.738

8.  Electroconvulsive therapy in pregnancy.

Authors:  J T Repke; N G Berger
Journal:  Obstet Gynecol       Date:  1984-03       Impact factor: 7.661

Review 9.  Sexuality, reproduction, and family planning in women with schizophrenia.

Authors:  L J Miller
Journal:  Schizophr Bull       Date:  1997       Impact factor: 9.306

10.  Pregnancy and delivery complications in the births of an unselected series of Finnish children with schizophrenic mothers.

Authors:  G Wrede; S A Mednick; M O Huttunen; C G Nilsson
Journal:  Acta Psychiatr Scand       Date:  1980-10       Impact factor: 6.392

View more
  3 in total

Review 1.  Antipsychotic therapy during early and late pregnancy. A systematic review.

Authors:  Salvatore Gentile
Journal:  Schizophr Bull       Date:  2008-09-11       Impact factor: 9.306

Review 2.  Perinatal depression: treatment options and dilemmas.

Authors:  Teri Pearlstein
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

Review 3.  Effects of obstetric analgesics and anesthetics on the neonate : a review.

Authors:  Jay E Mattingly; John D'Alessio; Jaya Ramanathan
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.